Medication info

Pencain Cream

Prescription medicationCreamExpired
Ingredient · strength
Lidocaine›25mg / 1gPrilocaine›25mg / 1g
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
White cream formulation
Packaging
5g/tube
Approval status
Expired

MFDS item code 201600937 · Notified 2016.02.18

This product's status changed to Expired on 2026.02.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Control of pain by topical anesthesia during treatment of the skin, genital mucosa, and leg ulcers
Who uses it
Adults · Children
Adult dosage
1. Skin: After applying this medicine, cover the area with an occlusive dressing. The application site should generally remain covered for 1-3 hours, and the effect lasts for at least 1 hour after removal of the occlusive dressing. 1) For needle insertion (e.g., intravenous cannulation, blood sampling), apply approximately 2g of this medicine for a minimum of 1 hour and a maximum of 5 hours. 2) For minor superficial surgery [e.g., removal of molluscum contagiosum], apply 1.5 -2g/10㎠ for 1 hour. 3) For major superficial surgery (e.g., split-thickness skin grafting), apply 1.5-2g/10㎠ for a minimum of 2 hours and a maximum of 5 hours. 2. Genital mucosa: For removal of condylomas, apply approximately 10g of this medicine to the treatment area for 5-10 minutes, then remove this medicine and begin the procedure immediately. 3. Leg ulcers: After applying this medicine, cover the area with an occlusive dressing. Use an opened tube for a single application and discard any remaining cream after each procedure. Apply 1-2g/10cm<sup>2</sup> for at least 30 minutes, and do not exceed 10g per treatment. For leg ulcers with tissue that is difficult to treat, the application time may be extended to 60 minutes; cleanse the ulcer within 10 minutes after removing the cream. When used up to 15 times over 1-2 months, the effect did not decrease and local reactions did not increase.
Children's dosage
Infants aged 3 months-12 months: Total amount 2g; do not exceed an application area of 16㎠.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Control of pain by topical anesthesia during treatment of the skin, genital mucosa, and leg ulcers

View approved original text

This medication is used for surface anesthesia of the skin during the insertion of needles or superficial surgical procedures. It is also used to reduce pain by providing surface anesthesia of the mucous membranes of the genital area, for example, before the removal of condylomas. It helps to alleviate discomfort during cleaning or superficial surgery in areas such as leg ulcerations. This drug effectively provides local anesthesia in these various situations, helping to reduce pain. Therefore, it offers a safe and comfortable treatment environment for injections, surgical procedures, and mucosal anesthesia.

Dosage and Administration

Adult dosage

1. Skin: After applying this medicine, cover the area with an occlusive dressing. The application site should generally remain covered for 1-3 hours, and the effect lasts for at least 1 hour after removal of the occlusive dressing. 1) For needle insertion (e.g., intravenous cannulation, blood sampling), apply approximately 2g of this medicine for a minimum of 1 hour and a maximum of 5 hours. 2) For minor superficial surgery [e.g., removal of molluscum contagiosum], apply 1.5 -2g/10㎠ for 1 hour. 3) For major superficial surgery (e.g., split-thickness skin grafting), apply 1.5-2g/10㎠ for a minimum of 2 hours and a maximum of 5 hours. 2. Genital mucosa: For removal of condylomas, apply approximately 10g of this medicine to the treatment area for 5-10 minutes, then remove this medicine and begin the procedure immediately. 3. Leg ulcers: After applying this medicine, cover the area with an occlusive dressing. Use an opened tube for a single application and discard any remaining cream after each procedure. Apply 1-2g/10cm<sup>2</sup> for at least 30 minutes, and do not exceed 10g per treatment. For leg ulcers with tissue that is difficult to treat, the application time may be extended to 60 minutes; cleanse the ulcer within 10 minutes after removing the cream. When used up to 15 times over 1-2 months, the effect did not decrease and local reactions did not increase.

Children's dosage

Infants aged 3 months-12 months: Total amount 2g; do not exceed an application area of 16㎠.

Precautions

This drug is used as a local anesthetic and may cause a rare blood disorder known as methemoglobinemia. This condition reduces the oxygen-carrying capacity of the blood, possibly causing the skin to take on a bluish hue or, in severe cases, leading to problems in the central nervous system and heart. Patients with glucose-6-phosphate dehydrogenase deficiency, congenital methemoglobinemia, heart or lung diseases, infants under 6 months of age, and those using specific oxidizing agents should exercise extra caution. While using this drug, one must closely monitor for symptoms and signs of methemoglobinemia, and if symptoms appear, usage must be immediately stopped and treatment sought. Additionally, this drug should not be used on individuals with hypersensitivity to it, in areas with wounds or dermatitis, in infants under 3 months, and in infants under 12 months or premature infants who are taking specific medications. Anemia, frail patients, elderly individuals, and those with liver diseases should use with caution, and precaution is necessary if allergic to any of the components of this drug. When applied to the skin, temporary pallor, redness, swelling, burning sensation, itching, local sensitization reactions, numbness, and skin irritation may occur, and rarely, severe allergic reactions or anaphylactic shock may happen. It may cause irritation if it comes in contact with the eyes, so it should not be applied around the eyes; if contact occurs, it should be rinsed immediately with clean water. The toxicity may be increased when this drug is used with other local anesthetics or certain medications, so caution is advised during concomitant use. Pregnant or breastfeeding women should use it cautiously after consulting with a doctor, and it should be used restrictively in children, especially infants under 3 months. Overdosage may lead to symptoms of methemoglobinemia or adverse effects on the central nervous system and cardiovascular system, therefore, the dosage must be strictly followed, and any abnormal symptoms should be reported to healthcare professionals immediately. Finally, it is advisable to avoid prolonged or high-dose usage of this drug, and if any adverse reactions or suspicious symptoms occur during use, immediate consultation with a specialist should be sought.

Side effects

  • Pallor
  • erythema
  • edema
  • mild initial burning sensation
  • itching
  • purpura
  • petechiae
  • methemoglobinemia
  • allergic reactions
  • anaphylactic shock
Show 3 more
  • corneal irritation
  • paresthesia
  • skin irritation

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to prevent exposure to air or moisture, and it is safe to store at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White cream formulation

Package unit

5g/tube

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.